Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Almirall Selects Second Target In Absci Collaboration To Accelerate AI-Driven Therapeutics For Severe Skin Conditions

Author: Benzinga Newsdesk | August 07, 2025 02:48am

Almirall selects second target in AI Drug Creation collaboration
Expanded collaboration builds on Absci's successful de novo molecule design for difficult‑to‑drug targets in the first stage of the collaboration with Almirall

Posted In: ABSI